Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
BridgeBio Pharma, Inc. (BBIO)
Sector: Healthcare; Industry: Biotechnology

BridgeBio Pharma, Inc. discovers and develops various medicines for genetic diseases. In addition, it is involved in the development of; BBP-551 to treat inherited retinal disease; BBP-472 to treat autism-spectrum disorder; BBP-009/Patidegib to treat gorlin syndrome and high-frequency basal cell carcinoma; BBP-589/PTR-01 to treat recessive dystrophic epidermolysis bullosa; BBP-681 to treat venous and lymphatic malformations; BBP-561 to treat netherton syndrome; BBP-398 to treat cancer; BBP-954 to treat solid and hematological cancers; BBP-812 for canavan disease; and BBP-815 to treat nonsyndromic hearing loss.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 STEPHENSON BRIAN C nan Buy 8,000 $62.50 $500,000 Yes
2021-02-17 Scott Randal W. Director Buy 16,000 $62.50 $1,000,000 No
2021-02-17 KKR Genetic Disorder L.P. 10%-Owner Sell 3,450,000 $60.47 $208,617,360 No
2020-12-28 Turtle Cameron nan Sell 19,500 $69.60 $1,357,184 Yes
2020-12-21 SCHELLER RICHARD H Director Sell 60,401 $65.32 $3,945,137 No
2020-12-18 SCHELLER RICHARD H Director Sell 30,000 $65.07 $1,952,021 No
2020-12-15 SCHELLER RICHARD H Director Sell 31,443 $60.38 $1,898,417 Yes
2020-12-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $51.52 $515,204 Yes
2020-06-03 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 784 $30.04 $23,549 No
2020-11-25 Turtle Cameron nan Sell 5,000 $47.04 $235,181 Yes
2020-11-16 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $45.00 $450,000 Yes
2020-11-13 MCCORMICK FRANK Chairman of Oncology Sell 100,000 $42.76 $4,275,769 No
2020-11-05 Turtle Cameron nan Sell 2,500 $42.05 $105,125 Yes
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $38.36 $383,558 Yes
2020-10-16 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 10,256 $41.00 $420,496 Yes
2020-10-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $38.83 $388,342 Yes
2020-09-30 Turtle Cameron nan Sell 14,500 $37.69 $546,458 Yes
2020-09-30 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 10,000 $38.00 $380,000 Yes
2020-09-29 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 99,257 $36.95 $3,667,955 No
2020-09-18 Turtle Cameron nan Sell 2,500 $42.01 $105,024 Yes
2020-09-18 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $40.00 $400,000 Yes
2020-09-16 SCHELLER RICHARD H Director Sell 25,000 $37.50 $937,500 No
2020-09-15 Turtle Cameron nan Sell 2,500 $37.06 $92,652 Yes
2020-09-11 Turtle Cameron nan Sell 2,000 $35.02 $70,047 Yes
2020-09-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $28.73 $287,334 Yes
2020-08-04 STEPHENSON BRIAN C nan Sell 7,200 $27.26 $196,289 No
2020-08-04 Kumar Neil CEO and President Sell 80,000 $27.23 $2,178,066 No
2020-08-03 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $27.37 $273,741 Yes
2020-07-02 Kumar Neil CEO and President Sell 143,470 $30.75 $4,411,357 No
2020-07-01 STEPHENSON BRIAN C nan Sell 10,800 $30.93 $334,053 No

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.